Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tofacitinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109503462B details a novel synthesis for Tofacitinib intermediates, offering improved stereoselectivity and cost reduction in API manufacturing through optimized catalytic hydrogenation.
Patent CN111793017B reveals Ru-catalyzed asymmetric hydrogenation for lactam intermediates. Offers high purity, safety without hydrogen gas, and scalable pharma manufacturing solutions.